ARCHIVES

Broder Emerges As National Leader In ASCO Talk, Calls For Faster Reporting Of Clinical

This article is from The Cancer Letter archive.

Vol. 15 No. 22 | June 2, 1989

Download PDF Visit The Full Archive

Related Articles

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

Three Community Based Programs Slated for Early Phaseout, Others Modified, Provided NCAB Agrees

February 29, 1980

Seventeen of 23 CHOPs Approved For Implementation

July 16, 1982

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

In Brief: NCI Gets $867 Million From Conferees; Grants To Be Funded At 41-42% Including Some Holdovers

July 29, 1977